Metabolic Syndrome as a Risk Factor for Cardiovascular Disease, Mortality, and Progression of Diabetic Nephropathy in Type 1 Diabetes
Lena M. Thorn(University of Helsinki), Johan Wadén(Helsinki University Hospital), Carol Forsblom(University of Helsinki), Nina Tolonen(University of Helsinki), Markku Saraheimo(Helsinki University Hospital), Kustaa Hietala(Helsinki University Hospital), Per‐Henrik Groop(University of Helsinki)
Cited by 117
Related Papers
The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
|Diabetes|2009|641
Metabolomics Reveals Signature of Mitochondrial Dysfunction in Diabetic Kidney Disease
|Journal of the American Society of Nephrology|2013|578
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
|Diabetes|1999|509
Metabolic Syndrome in Type 1 Diabetes
|Diabetes Care|2005|428